Glucose monitoring products provider Dexcom has signed a development agreement with Eli Lilly to combine their tools for offering better diabetes management to patients.
22 November 2017 News
2 November 2017 News
Digital diabetes care platform One Drop has entered a multi-part collaboration to leverage Fitbit’s wearable data for providing data-driven care management tools to the diabetes community.
2 October 2017
On 29 September, Abbott received FDA approval for the FreeStyle Libre Flash continuous glucose monitor (CGM).
26 September 2017
As part of our series of white papers tracking clinical trials activity across the world, GlobalData recently compiled a summary of the clinical trials initiated in Japan.
17 August 2017
Glytec has received its fourth clearance from the US Food and Drug Administration (FDA) for its diabetes therapy management software, Glucommander.
15 August 2017
US-based Tandem Diabetes Care has started patient enrolment for the PROLOG clinical trial of its t:slim X2 Insulin Pump featuring predictive low glucose suspend (PLGS) technology.
16 July 2017
Abbott has signed an agreement to integrate its FreeStyle Libre glucose sensing technology with Bigfoot Biomedical’s insulin delivery solutions to develop and commercialise diabetes management systems in the US.
11 July 2017
French firm Defymed has developed a new insulin delivery device ExOlin to facilitate better disease management for both type 1 and type 2 diabetes patients.
3 July 2017
Roche has purchased all shares of Austria-based mobile diabetes platform mySugr, strengthening its digital health services for diabetes care.
11 June 2017
Switzerland-based Ascensia Diabetes Care has entered a global technology partnership with French firm Voluntis to optimise insulin management for patients suffering from type 2 diabetes.